Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 251.56 +9.48 (3.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $242.08 | 52 Week High | $0.52 | |||
| Open | $242.20 | 52 Week Low | $0.08 | |||
| Day High | $253.03 | P/E | N/A | |||
| Day Low | $239.55 | EPS | $-3.80 | |||
| Volume | 10,700,566 | |||||
